Literature DB >> 15975576

Mass spectroscopy identifies the splicing-associated proteins, PSF, hnRNP H3, hnRNP A2/B1, and TLS/FUS as interacting partners of the ZNF198 protein associated with rearrangement in myeloproliferative disease.

Chitta S Kasyapa1, Padmaja Kunapuli, John K Cowell.   

Abstract

ZNF198 is fused with FGFR1 in an atypical myeloproliferative disease that results in constitutive activation of the kinase domain and mislocalization to the cytoplasm. We have used immunoprecipitation of a GFP-tagged ZNF198 combined with MALDI-TOF mass spectroscopy to identify interacting proteins. P splicing factor (PSF) was identified as one of the proteins and this interaction was confirmed by Western blotting. Other proteins identified were the spliceosomal components hnRNP A2/B1, hnRNP H3, and TLS/FUS. PSF is also known to interact with PTB, another member of the hnRNP family of proteins, and we further demonstrated that PTB interacts with ZNF198. The interaction between TLS/FUS and ZNF198 was confirmed using Western blot analysis. In 293 cells expressing the ZNF198/FGFR1 fusion protein, neither PSF nor PTB binds to the fusion protein, possibly because of their differential localization in the cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975576     DOI: 10.1016/j.yexcr.2005.05.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.

Authors:  Chitta S Kasyapa; Padmaja Kunapuli; Lesleyann Hawthorn; John K Cowell
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

Review 2.  The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.

Authors:  Oliver D King; Aaron D Gitler; James Shorter
Journal:  Brain Res       Date:  2012-01-21       Impact factor: 3.252

3.  Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.

Authors:  Stephen Mallon; Bassam T Wakim; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

4.  Incorporating significant amino acid pairs and protein domains to predict RNA splicing-related proteins with functional roles.

Authors:  Justin Bo-Kai Hsu; Kai-Yao Huang; Tzu-Ya Weng; Chien-Hsun Huang; Tzong-Yi Lee
Journal:  J Comput Aided Mol Des       Date:  2014-01-19       Impact factor: 3.686

5.  Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.

Authors:  Chitta Kasyapa; Ting-Lei Gu; Lalitha Nagarajan; Lalitha Natarajan; Roberto Polakiewicz; John K Cowell
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

6.  Identification of cellular proteins that interact with the adeno-associated virus rep protein.

Authors:  Kevin Nash; Weijun Chen; Max Salganik; Nicholas Muzyczka
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

7.  Complex evolutionary relationships among four classes of modular RNA-binding splicing regulators in eukaryotes: the hnRNP, SR, ELAV-like and CELF proteins.

Authors:  Yue Hang Tang; Siew Ping Han; Karin S Kassahn; Adam Skarshewski; Joseph A Rothnagel; Ross Smith
Journal:  J Mol Evol       Date:  2012-11-24       Impact factor: 2.395

8.  Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.

Authors:  Zhihui Sun; Zamia Diaz; Xiaodong Fang; Michael P Hart; Alessandra Chesi; James Shorter; Aaron D Gitler
Journal:  PLoS Biol       Date:  2011-04-26       Impact factor: 8.029

9.  Crypton transposons: identification of new diverse families and ancient domestication events.

Authors:  Kenji K Kojima; Jerzy Jurka
Journal:  Mob DNA       Date:  2011-10-19

10.  Incorporating evolutionary information and functional domains for identifying RNA splicing factors in humans.

Authors:  Justin Bo-Kai Hsu; Neil Arvin Bretaña; Tzong-Yi Lee; Hsien-Da Huang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.